

Norstella
"Pharmaceutical intelligence solutions that guide therapies from pipeline to patient"
About Norstella
Norstella provides data, analytics, and AI-powered intelligence to pharmaceutical, biotech, and medtech companies navigating drug development complexities. Through brands including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group, it delivers insights across clinical trial design, market forecasting, payer access, real-world data analysis, and physician engagement. The company helps life sciences organisations bring therapies to patients efficiently. By combining proprietary datasets with AI capabilities, Norstella identifies market access barriers, supports trial design, and activates healthcare providers. Its solutions enable faster, informed decisions in an industry managing over $300 billion in annual R&D investment.


1600
Team Members
1994
Founded
Private Equity
Funding
Hybrid
Work Environment
A world where every patient gains timely access to life-saving therapies because pharmaceutical companies can navigate drug development complexities with complete clarity and confidence.
At Norstella, our mission is to smooth the path to life-saving therapies for patients and providers.